Rhythm Pharmaceuticals Files 8-K
Ticker: RYTM · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1649904
| Field | Detail |
|---|---|
| Company | Rhythm Pharmaceuticals, Inc. (RYTM) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: RHYM
TL;DR
RHYTHM PHARMACEUTICALS FILED AN 8-K. CHECK FOR UPDATES.
AI Summary
Rhythm Pharmaceuticals, Inc. filed an 8-K on April 7, 2025, to report on other events and financial statements. The filing does not contain specific details about new material events or financial figures within the provided text.
Why It Matters
This filing indicates Rhythm Pharmaceuticals is providing updates to the SEC, which could include significant corporate events or financial information relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without immediate disclosure of negative or positive material events.
Key Players & Entities
- RHYTHM PHARMACEUTICALS, INC. (company) — Registrant
- April 7, 2025 (date) — Date of earliest event reported
- 222 Berkeley Street 12th Floor Boston, MA 02116 (location) — Principal executive offices address
- 001-38223 (other) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of April 7, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is April 7, 2025.
What is the principal executive office address for Rhythm Pharmaceuticals, Inc.?
The principal executive office address is 222 Berkeley Street, 12th Floor, Boston, MA 02116.
What is the SEC file number for Rhythm Pharmaceuticals, Inc.?
The SEC file number for Rhythm Pharmaceuticals, Inc. is 001-38223.
What is the SIC code for Rhythm Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Rhythm Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding RHYTHM PHARMACEUTICALS, INC. (RYTM).